Iran Press/ Iran news: Asghar Abdoli said Iran needs to initially submit all the required documents about its homemade vaccine to WHO and defend its scientific claims and documents.
He added that the first article on the pre-clinical or animal studies phase of COVIran Barakat would be published soon.
In mid-June, Iran published the 1st article on COVIran Barakat at BioRxiv.
The article was titled: "Safety and Potency of COVIran Barakat Inactivated Vaccine Candidate for SARS-CoV-2: A Preclinical Study."
"There is an urgent demand to manufacture an effective and safe vaccine to prevent SARS-CoV2 infection, which resulted in a global pandemic," the article's abstract said.
Mass production of the Iranian-made anti-coronavirus began at a pharmaceutical factory run by the Execution of Imam Khomeini Order (EIKO) in Tehran in mid-May.
207/224
Read More:
Iran increases production of COVIran Barekat vaccine
Results of 1st phase of COVIran Barekat vaccine announced
